MarketPeel
Insider Trading Intelligence
OL

Orbimed Rof II Llc

XTNT
DIRECTOR · XTANT MEDICAL HOLDINGS, INC. · CIK 0001767936
FILING MIX · LIFETIME68%/32%
BUYS
13
SELLS
6
TOTAL VALUE
$93.62M
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
0
AVG SELL PX
$0.42
TRADE KIND
SHOWING 19 / 19
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Orbimed Rof II Llc, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+0.00%+18.42%+0.35%+18.07%+18.07%
14d2+0.00%+26.32%+4.21%+22.10%+22.10%
30d2+0.00%+31.58%+7.58%+24.00%+24.00%
60d2+0.00%+76.32%+14.32%+62.00%+62.00%
90d2+0.00%+71.05%+18.96%+52.09%+52.09%
180d2+0.00%+76.32%+27.55%+48.76%+48.76%
1y2+0.00%+26.32%+29.52%-3.21%-3.21%
2y2(2 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
XTNT · 0 shares · as of Apr 10, 2025
013,941,58827,883,17641,824,76455,766,35220212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
FLOW · 13 buys / 6 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
XTNT
XTANT MEDICAL HOLDINGS, INC.
SALE
17,109,618$0.42$7.19M0Apr 10, 2025Apr 14, 2025View →
XTNT
XTANT MEDICAL HOLDINGS, INC.
SALE
56,004,974$0.42$23.52M0Apr 10, 2025Apr 14, 2025View →
XTNT
XTANT MEDICAL HOLDINGS, INC.
PURCHASE
215,415215,415Aug 15, 2022Aug 17, 2022View →
XTNT
XTANT MEDICAL HOLDINGS, INC.
PURCHASE
85,337120,549Aug 15, 2021Aug 17, 2021View →
XTNT
XTANT MEDICAL HOLDINGS, INC.
PURCHASE
765,992$0.01$7.7K54,234,368Nov 17, 2020Nov 19, 2020View →
XTNT
XTANT MEDICAL HOLDINGS, INC.
SALE
765,9920Nov 17, 2020Nov 19, 2020View →
XTNT
XTANT MEDICAL HOLDINGS, INC.
SALE
434,0080Nov 17, 2020Nov 19, 2020View →
XTNT
XTANT MEDICAL HOLDINGS, INC.
SALE
1,531,9840Nov 17, 2020Nov 19, 2020View →
XTNT
XTANT MEDICAL HOLDINGS, INC.
PURCHASE
434,008$0.01$4.3K16,168,704Nov 17, 2020Nov 19, 2020View →
XTNT
XTANT MEDICAL HOLDINGS, INC.
PURCHASE
1,531,984$0.01$15.3K55,766,352Nov 17, 2020Nov 19, 2020View →
XTNT
XTANT MEDICAL HOLDINGS, INC.
PURCHASE
434,008$0.01$4.3K15,734,696Nov 17, 2020Nov 19, 2020View →
XTNT
XTANT MEDICAL HOLDINGS, INC.
SALE
868,0160Nov 17, 2020Nov 19, 2020View →
XTNT
XTANT MEDICAL HOLDINGS, INC.
PURCHASE
868,016$0.01$8.7K17,036,720Nov 17, 2020Nov 19, 2020View →
XTNT
XTANT MEDICAL HOLDINGS, INC.
PURCHASE
765,992$0.01$7.7K53,468,376Nov 17, 2020Nov 19, 2020View →
XTNT
XTANT MEDICAL HOLDINGS, INC.
PURCHASEGRANT
Stock grant
46,784,775$1.07$50.06M52,702,384Oct 1, 2020Oct 5, 2020View →
XTNT
XTANT MEDICAL HOLDINGS, INC.
PURCHASEGRANT
Stock grant
11,969,619$1.07$12.81M15,300,688Oct 1, 2020Oct 5, 2020View →
XTNT
XTANT MEDICAL HOLDINGS, INC.
PURCHASEGRANT
Stock grant
868,016868,016May 6, 2020May 20, 2020View →
XTNT
XTANT MEDICAL HOLDINGS, INC.
PURCHASEGRANT
Stock grant
1,531,9841,531,984May 6, 2020May 20, 2020View →
XTNT
XTANT MEDICAL HOLDINGS, INC.
PURCHASE
70,42391,256Feb 5, 2020Feb 7, 2020View →
Other insiders · XTNT
Loading peer insiders…
About this filer
CIK 0001767936
ROLE
Director
PRIMARY
XTNT
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001767936DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback